Environmental Clean Technologies Opens Industrial MXene Markets with Drexel
TechnologyECT’s Xenica target secures a Drexel licence opening MXene markets in energy storage, coatings and filtration, with defence still first priority.Nik HillJournalist · 2 min readIn this storyASX:ECTIn…
ECT’s Xenica target secures a Drexel licence opening MXene markets in energy storage, coatings and filtration, with defence still first priority.
Nik HillJournalist · 2 min readIn this storyASX:ECTIn briefAt-a-glance3 takeaways- 01Xenica secured Drexel rights for industrial MXene uses, including energy storage, coatings and filtration.
- 02Defence remains ECT’s first commercial priority.
- 03Licence depends on ECT completing the acquisition; scale-up and sales are unproven.
Environmental Clean Technologies (ASX: ECT) has widened its prospective MXene markets after acquisition target Xenica obtained a worldwide, non-exclusive commercial licence from Drexel University.
The agreement allows Xenica to make, use, import, and sell MXene materials across specified industrial applications, adding to its existing rights for military and defence-related uses.
Energy storage, industrial coatings, and water filtration are among the additional opportunities, although defence remains the initial commercial priority.
The expansion is conditional on ECT completing its acquisition of Xenica and does not establish manufacturing readiness or immediate sales.
Broader Route to Customers
Drexel holds foundational patents for MXenes, a class of materials discovered at the university in 2011, making the new licence a significant addition to Xenica’s existing intellectual property arrangements.
Its earlier sublicence from MXene Inc. covered military end uses, whereas the latest arrangement permits specified non-military products without requiring separate access to the same Drexel patents for each prospective customer.
Potential applications range from conductive additives for fast-charging batteries and supercapacitors to industrial coatings, composites and filtration products.
The licence excludes electromagnetic interference shielding, dialysis, biosignal electrodes, antennas, infrared shielding, and military uses, with the latter covered separately by Xenica’s defence sublicence.
Drexel will receive royalties on future sales under the new licence, which runs until the relevant patent rights expire.
AdvertisementManufacturing Framework
ECT expects to complete the Xenica acquisition over the coming weeks, bringing together a production technology licence from Rice University and access to US manufacturing infrastructure.
That infrastructure includes Metallium (ASX: MTM)’s commissioned Gator Point reactor, available through a research, development, and engineering agreement rather than construction of a new plant.
Initial MAX Phase precursor supply has been arranged for manufacturing development, alongside the defence sublicence and the new commercial rights.
Xenica produced its first MXene material in October, but commercial-scale output still requires proof of repeatable production, consistent product quality and viable economics.
The group intends to validate material independently before supplying customer samples and pursuing product qualification and commercial agreements.
AdvertisementDefence Leads Commercial Rollout
ECT plans to retain defence customers as the first qualification priority while developing selected industrial applications alongside that work.
“In three months we have brought together exclusive production technology, access to a commissioned US reactor, precursor supply, and licensed market access—the Drexel Licence adds an important piece of that framework,” executive chair Faldi Ismail said.
“Defence remains our first market, but we can now pursue industrial opportunities in energy storage, coatings and filtration in parallel.”
Further work at Gator Point will focus on improving production yield and consistency before independently testing whether the materials meet application-specific requirements.
“Our job is to convert these capabilities into repeatable manufacturing, qualified products, customers and, ultimately, revenue—that is where our focus now lies,” Mr Ismail added.
Subscribe · daily wireGet the wire before the market opens.
The ASX small-cap stories that matter, filed before 9am AEST. Curated by the Small Caps desk.
Join 100,000+ investors. Unsubscribe anytime.Filed underTechnologyASX:ECTShareAbout the authorNik Hill
JournalistView all articlesMore like this
View all latestFigures reflect the source report and its stated period. This article is for information and is not investment advice.
